Pacritinib (citrate), CAS [[1228923-42-9]]

Product Overview

• Article Name: Pacritinib (citrate), CAS [[1228923-42-9]]
• Biozol Catalog Number: MCE-HY-16379B
• Supplier Catalog Number: HY-16379B
• Alternative Catalog Number: MCE-HY-16379B-10MG,MCE-HY-16379B-5MG,MCE-HY-16379B-50MG,MCE-HY-16379B-10MMX1ML,MCE-HY-16379B-25MG,MCE-HY-16379B-100MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: SB1518 (citrate)

Product Description

Pacritinib (SB1518) citrate is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM). Pacritinib citrate also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM). Pacritinib citrate can be used for the research of acute myeloid leukemia (AML) and myelofibrosis (MF)[1][2][3].

Product Properties

• Molecular Weight: 664.70
• Purity: 99.68
• CAS Number: [1228923-42-9]
• Formula: C34H40N4O10
• Target: FLT3,JAK

Application Notes

• Application Notes: Reference compound